Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A. +6 more·1998·Journal of Neural Transmission
DOI 10.1007/s007020050068

Cited by (746)

Items 101–200 of 746

  1. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update
    Siegfried Hoyer · 2002 · Journal of Neural Transmission
  2. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
    Cioffi, Federica, Adam, Rayan Hassan Ibrahim, Broersen, Kerensa · 2019 · Journal of Alzheimer s Disease
  3. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins
    Prashant Bharadwaj, Nadeeja Wijesekara, Milindu Liyanapathirana, Philip Newsholme, Lars Matthias Ittner, Paul E. Fraser, Giuseppe Verdile · 2017 · Journal of Alzheimer s Disease
  4. Type 2 Diabetes and Cognitive Impairment: Linking Mechanisms
    Jose Alejandro Luchsinger · 2012 · Journal of Alzheimer s Disease
  5. Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions
    Michelle A. Erickson, William A. Banks · 2019 · International Journal of Molecular Sciences
  6. Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?
    Molly Stanley, Shannon L. Macauley, David M. Holtzman · 2016 · The Journal of Experimental Medicine
  7. Type 2 diabetes and risk of cognitive impairment and dementia
    Rachel A. Whitmer · 2007 · Current Neurology and Neuroscience Reports
  8. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies
    Kyriaki Gerozissis · 2008 · European Journal of Pharmacology
  9. Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
    Sónia C. Correia, Renato X. Santos, Cristina Carvalho, Susana Cardoso, Emanuel Candeias, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2012 · Brain Research
  10. Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
    Malka Shilo, Menachem Motiei, Panet Hana, Rachela Popovtzer · 2013 · Nanoscale
  11. Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
    M. Shukla, P. Govitrapong, Parichart Boontem, R. Reiter, J. Satayavivad · 2017 · Current Neuropharmacology
  12. Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype
    S. Craft, S. Asthana, G. Schellenberg, L. Baker, M. Cherrier, Adam A. Boyt, R. Martins, M. Raskind, E. Peskind, S. Plymate · 2000 · Annals of the New York Academy of Sciences
  13. Untitled work
    2000 · 10.1002/1520-7560(2000)9999:9999
  14. Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
    Anusha Jayaraman, Christian J. Pike · 2014 · Current Diabetes Reports
  15. Impaired insulin signalling and allostatic load in Alzheimer disease
    Fernanda G. De Felice, Rafaella Araujo Gonçalves, Sergio Teixeira Ferreira · 2022 · Nature reviews. Neuroscience
  16. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice
    Yingqi Wang, Oksana Berezovska, SERGEY FEDOROFF · 1999 · Journal of Neuroscience Research
  17. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
    Corinne G. Jolivalt, Rosemarie Hurford, Corinne A. Lee, Wilmar Dumaop, Edward M. Rockenstein, Eliezer Masliah · 2009 · Experimental Neurology
  18. Brain insulin resistance: role in neurodegenerative disease and potential for targeting
    Hölscher, Christian · 2020 · Expert Opinion on Investigational Drugs
  19. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update
    Siegfried Hoyer · 2000 · Experimental Gerontology
  20. Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications
    Siegfried Hoyer · 2004 · Advances in experimental medicine and biology
  21. Insulin action in the brain: cell types, circuits, and diseases
    Wenqiang Chen, Weikang Cai, Benjamin Hoover, C. Ronald Kahn · 2022 · Trends in Neurosciences
  22. Brain meets body: the blood-brain barrier as an endocrine interface.
    W. Banks · 2012 · Endocrinology
  23. The Role of Insulin, Insulin Growth Factor, and Insulin‐Degrading Enzyme in Brain Aging and Alzheimer′s Disease
    Claude Messier, Kevin Teutenberg · 2005 · Neural Plasticity
  24. Enriched environment and acceleration of visual system development
    Alessandro Sale, Elena Putignano, Laura Cancedda, Silvia Landi, Francesca Cirulli, Nicoletta Berardi, Lamberto Maffei · 2004 · Neuropharmacology
  25. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia
    Rahul Agrawal, Ethika Tyagi, Rakesh Shukla, Chandishwar Nath · 2009 · Neuropharmacology
  26. Effect of Intranasal Insulin on Cognitive Function: A Systematic Review
    Shemesh, Elad, Rudich, Assaf, Harman-Boehm, Ilana, Cukierman-Yaffe, Tali · 2012 · The Journal of Clinical Endocrinology & Metabolism
  27. Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
    Rim Hamzé, Etienne Delangre, Stéfania Tolu, Manon Moreau, Nathalie Janel, Danielle Bailbé, Jamileh Movassat · 2022 · International Journal of Molecular Sciences
  28. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review
    Siegfried Hoyer · 2002 · Journal of Neural Transmission
  29. Insulin resistance and pathological brain ageing
    Brenna Cholerton, Laura D. Baker, Suzanne Craft · 2011 · Diabetic Medicine
  30. A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease
    Lutz Frölich, Doris Blum-Degen, Peter Franz Riederer, Siegfried Hoyer · 1999 · Annals of the New York Academy of Sciences
  31. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
    Beeri, M. S., Schmeidler, J., Silverman, J. M., Gandy, S., Wysocki, M., Hannigan, C. M., Purohit, D. P., Lesser, G., Grossman, H. T., Haroutunian, V. · 2008 · Neurology
  32. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
    Giulio Maria Pasinetti, Jacqueline A. Eberstein · 2008 · Journal of Neurochemistry
  33. Insulin and Alzheimer's Disease: Untangling the Web
    Suzanne Craft, Brenna Cholerton, Laura D. Baker · 2012 · Journal of Alzheimer s Disease
  34. Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
    Latha Devi, Melissa J. Alldred, Stephen D. Ginsberg, Masuo Ohno · 2012 · PLoS ONE
  35. Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender
    Craft, Suzanne, Asthana, Sanjay, Schellenberg, Gerard, Cherrier, Monique, Baker, Laura D., Newcomer, John, Plymate, Stephen, Latendresse, Shawn, Petrova, Andreana, Raskind, Murray et al. · 1999 · Neuroendocrinology
  36. Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
    Zhao, Wei-Qin, Lacor, Pascale N., Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L. · 2009 · Journal of Biological Chemistry
  37. Insulin transport across the blood–brain barrier can occur independently of the insulin receptor
    Elizabeth M. Rhea, Christian Rask‐Madsen, William A. Banks · 2018 · The Journal of Physiology
  38. GluT4: A central player in hippocampal memory and brain insulin resistance
    Ewan C. McNay, Jiah Pearson-Leary · 2019 · Experimental Neurology
  39. Hypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease
    2016
  40. Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model
    Rahul Agrawal, Ethika Tyagi, Rakesh Shukla, Chandishwar Nath · 2011 · European Neuropsychopharmacology
  41. Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
    Amaia Ezkurdia, María Javier Ramírez, Maite Solas · 2023 · International Journal of Molecular Sciences
  42. Insulin action in the brain regulates both central and peripheral functions
    Rahul Agrawal, Candace M. Reno, Sunny Sharma, CAMILLE G. CHRISTENSEN, Yiqing Huang, Simon J. Fisher · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  43. Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK 3β Pathway in Streptozotocin‐Induced A lzheimer Rat Model
    Chong Gao, Yueze Liu, Yuanhong Jiang, Jianming Ding, Lin Li · 2013 · Brain Pathology
  44. Brain Insulin Resistance in Alzheimer's Disease and its Potential Treatment with GLP-1 Analogs
    Konrad Talbot · 2014 · Neurodegenerative Disease Management
  45. The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease
    Konrad Talbot, Hoau-Yan Wang · 2014 · Alzheimer s & Dementia
  46. Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease
    Martı́n Gómez Ravetti, Osvaldo Anibal Rosso, Regina Esther Berretta, Pablo Moscato · 2010 · PLoS ONE
  47. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities
    Sara Santa-Cruz Calvo, Leena P. Bharath, Gabriella H. Pugh, Lucia SantaCruz-Calvo, Raji Rajesh Lenin, Jenny Lutshumba, Rui Liu, Adam D. Bachstetter, Beibei Zhu, Barbara S. Nikolajczyk · 2021 · Nature Reviews Endocrinology
  48. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease—The emerging role of systemic low-grade inflammation and adiposity
    Błażej Misiak, Jerzy Leszek, Andrzej Kiejna · 2012 · Brain Research Bulletin
  49. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study
    Melita Šalković‐Petrišić, Jelena Osmanović Barilar, Martina K. Brückner, Siegfried Hoyer, Thomas Arendt, Peter Franz Riederer · 2011 · Journal of Neural Transmission
  50. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
    Baruh Polis, Abraham O. Samson · 2020 · Neural Regeneration Research
  51. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
    Chakrabarti, Sasanka, Kumar Khemka, Vineet, Banerjee, Anindita, Chatterjee, Gargi, Ganguly, Anirban, Biswas, Atanu · 2015 · Aging and disease
  52. Type 2 Diabetes and Late-Onset Alzheimer’s Disease
    D. Cheng, James McC. Noble, M.‐X. Tang, Nicole Schupf, Richard P Mayeux, Jose Alejandro Luchsinger · 2011 · Dementia and Geriatric Cognitive Disorders
  53. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats
    Swapnil K. Sonkusare, K. K. Srinivasan, Chamanlal Kaul, Poduri Ramarao · 2005 · Life Sciences
  54. Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat
    Agrawal, Rahul, Mishra, Bhanvi, Tyagi, Ethika, Nath, Chandishwar, Shukla, Rakesh · 2010 · Pharmacological Research
  55. Brain Metabolic Alterations in Alzheimer’s Disease
    Carlos G. Ardanaz, María Javier Ramírez, Maite Solas · 2022 · International Journal of Molecular Sciences
  56. Diabetes and Alzheimer Disease, Two Overlapping Pathologies with the Same Background: Oxidative Stress
    Sergio Rosales‐Corral, Dun‐Xian Tan, Lucien C. Manchester, Russel Joseph Reiter · 2015 · Oxidative Medicine and Cellular Longevity
  57. Insulin, Aging, and the Brain: Mechanisms and Implications
    Abimbola A. Akintola, Diana van Heemst · 2015 · Frontiers in Endocrinology
  58. Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
    Rasoul Ghasemi, Leila Dargahi, Ali Haeri, Maryam Moosavi, Zahurin Mohamed, Abolhassan Ahmadiani · 2013 · Molecular Neurobiology
  59. Starvation and Triglycerides Reverse the Obesity-Induced Impairment of Insulin Transport at the Blood-Brain Barrier
    Akihiko Urayama, William A. Banks · 2008 · Endocrinology
  60. Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-β
    Melita Šalković‐Petrišić, Jelena Osmanović Barilar, Edna Grünblatt, Peter Franz Riederer, Siegfried Hoyer · 2009 · Journal of Alzheimer s Disease
  61. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
    Paul J. Meakin, Alex J. Harper, David Lee Hamilton, Jennifer R. Gallagher, Alison D. McNeilly, Laura A. Burgess, Lobke M. Vaanholt, Kirsten A. Bannon, Judy Latcham, Ishrut Hussain et al. · 2011 · Biochemical Journal
  62. The blood brain barrier in Alzheimer’s disease
    Chakraborty, A., de Wit, N.M., van der Flier, W.M., de Vries, H.E. · 2017 · Vascular Pharmacology
  63. Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-β Exposure
    Moreira, Paula I., Santos, Maria S., Moreno, António M., Seiça, Raquel, Oliveira, Catarina R. · 2003 · Diabetes
  64. Insulin resistance in Alzheimer's disease
    Thomas C. Diehl, Roger J. Mullins, Dimitrios Kapogiannis · 2016 · Translational research
  65. Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
    C. Hölscher · 2019 · Frontiers in Aging Neuroscience
  66. The Relevance of Insulin Action in the Dopaminergic System
    Francesca Fiory, Giuseppe Perruolo, Ilaria Cimmino, Serena Cabaro, Francesca Chiara Pignalosa, Claudia Miele, Francesco Bèguinot, Pietro Formisano, Francesco Oriente · 2019 · Frontiers in Neuroscience
  67. Cerebrovascular insulin receptors are defective in Alzheimer’s disease
    Manon Leclerc, Philippe Bourassa, Cyntia Tremblay, Vicky Caron, Camille Sugère, Vincent Émond, David Alan Bennett, Frédéric Calon · 2022 · Brain
  68. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains
    Kuhla, Björn, Boeck, Katharina, Schmidt, Angela, Ogunlade, Vera, Arendt, Thomas, Münch, Gerald, Lüth, Hans-Joachim · 2007 · Neurobiology of Aging
  69. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis
    G. Stennis Watson, Suzanne Craft · 2006 · Journal of the Neurological Sciences
  70. The cellular localization of the l-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems
    Hans-Gert Bernstein, Michael Müller · 1999 · Progress in Neurobiology
  71. Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer’s disease risk
    Bradley J. Baranowski, Daniel M. Marko, Rachel K. Fenech, Alex J. T. Yang, Rebecca E. K. MacPherson · 2020 · Applied Physiology, Nutrition, and Metabolism
  72. Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
    Ángeles Vinuesa, Carlos Javier Pomilio, Amal Gregosa, Melisa Bentivegna, Jessica Presa, Melina Bellotto, Flavia Saravia, Juan Beauquis · 2021 · Frontiers in Neuroscience
  73. Brain insulin and feeding: a bi-directional communication
    Kyriaki Gerozissis · 2004 · European Journal of Pharmacology
  74. Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review
    Rachel R Litke, Lorena Cancino Garcharna, Salima Jiwani, Judith A. Neugroschl · 2021 · Clinical Therapeutics
  75. Environmental enrichment prevents effects of dark-rearing in the rat visual cortex
    Alessandro Bartoletti, Paolo Medini, Nicoletta Berardi, Lamberto Maffei · 2004 · Nature Neuroscience
  76. Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease
    Milène Vandal, Phillip James White, Geneviève Chevrier, Cyntia Tremblay, Isabelle St‐Amour, Emmanuel Planel, André Marette, Frédéric Calon · 2015 · The FASEB Journal
  77. How Can Insulin Resistance Cause Alzheimer’s Disease?
    Ji Hye Yoon, Joohyun Hwang, Sung Un Son, Junhyuk Choi, Seung-Won You, Hyun‐Woo Park, Seung-Yun Cha, Sungho Maeng · 2023 · International Journal of Molecular Sciences
  78. In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin
    Audrey Kraska, Mathieu David Santin, Olène Dorieux, Nelly Joseph‐Mathurin, Emmanuel Bourrin, Fanny Petit, Caroline Jan, Marion Chaigneau, Philippe Hantraye, Pierre J. Lestage et al. · 2012 · PLoS ONE
  79. Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
    Angela J. Hanson, Jennifer L. Bayer-Carter, Pattie S. Green, Thomas Jude Montine, Charles W. Wilkinson, Laura D. Baker, G. Stennis Watson, Laura M. Bonner, Maureen Callaghan, James B. Leverenz et al. · 2013 · JAMA Neurology
  80. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
    Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
  81. Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
    Ian W. Weidling, Russell Howard Swerdlow · 2020 · Experimental Neurology
  82. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
    Mara Dierssen, Marta Fructuoso, María Martínez de Lagrán, Marzia Perluigi A, Eugenio Barone · 2020 · Frontiers in Neuroscience
  83. Brain Insulin Impairs Amyloid-β(1-40) Clearance from the Brain
    Takeshi Shiiki, Sumio Ohtsuki, Atsushi Kurihara, Hideo Naganuma, Kenji Nishimura, Masanori Tachikawa, Ken‐ichi Hosoya, Tetsuya Terasaki · 2004 · Journal of Neuroscience
  84. Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques
    Hans‐Gert Bernstein, Siegfried Ansorge, Peter Franz Riederer, Michael Reiser, Lutz Frölich, Bernhard Bogerts · 1999 · Neuroscience Letters
  85. The effects of cardiovascular risk factors on cognitive compromise
    Michal Schnaider Beeri, Ramit Ravona‐Springer, Jeremy M. Silverman, Vahram H. Haroutunian · 2009 · Dialogues in Clinical Neuroscience
  86. Mechanisms of Nitrosamine-Mediated Neurodegeneration: Potential Relevance to Sporadic Alzheimer's Disease
    Suzanne M. de la Monte, Ming Tong · 2009 · Journal of Alzheimer s Disease
  87. Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
    Bazzari, Firas H., Abdallah, Dalaal M., El-Abhar, Hanan S. · 2019 · Molecules
  88. Intracerebroventricular insulin improves spatial learning and memory in male Wistar rats.
    Vahid Hajali, Gisou Mohaddes, Shirin Babri · 2009 · Behavioral Neuroscience
  89. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats
    N. Rajasekar, Chandishwar Nath, Kashif Hanif, Rakesh Shukla · 2016 · Molecular Neurobiology
  90. Effect of aging on cellular mechanotransduction
    Miaozong Wu, Jacqueline C. Fannin, Kevin M. Rice, Bin Wang, Eric R. Blough · 2009 · Ageing Research Reviews
  91. Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
    Christian Benedict, Claudia A. Grillo · 2018 · Frontiers in Neuroscience
  92. Role of Insulin Resistance in the Alzheimer's Disease Progression
    Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Thuy Dung Nguyen, Thi Thuy Hang Le, Vo Van Giau · 2020 · Neurochemical Research
  93. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
    Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, Ángel Ortega, Manuel Nava, Juan José Salazar, Edgar Alexis Díaz-Camargo, Oscar Medina, Joselyn Rojas, Valmore Bermúdez · 2021 · World Journal of Diabetes
  94. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research
    Omar Yaxmehen Bello‐Chavolla, Neftali Eduardo Antonio‐Villa, Arsenio Vargas‐Vázquez, José Alberto Ávila‐Funes, Carlos Alberto Aguilar-Salinas · 2019 · Current Diabetes Reviews
  95. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases
    Calsolaro, Valeria, Edison, Paul · 2015 · CNS Drugs
  96. CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats
    Paula Isabel Moreira, Maria S. Santos, Cristina Maria Sena, E NUNES, Raquel Maria Fino Seiça, Catarina Resende Oliveira · 2005 · Experimental Neurology
  97. Metabolic Syndrome and Alzheimer's Disease: A Link to a Vascular Hypothesis?
    Haralampos J. Milionis, Matilda Florentin, Sotirios Giannopoulos · 2008 · CNS Spectrums
  98. Type 2 diabetes, related conditions, in relation and dementia: An opportunity for prevention?
    Luchsinger, José A. · 2010 · Journal of Alzheimer s Disease
  99. Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Scott C. Forbes, Jayna Marie Holroyd-Leduc, Marc J. Poulin, David B. Hogan · 2015 · Canadian Geriatrics Journal
  100. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1–40/42 and Phospho-Tau May Abet Alzheimer Development
    Mini P. Sajan, BARBARA CALEEN HANSEN, Robert A. Ivey, Joshua Sajan, Csilla Ari, Shijie Song, Ursula Braun, Michael Leitges, Margaret G. Higgs, Robert V. Farese · 2016 · Diabetes